Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC.
Lucibello F, Gounant V, Aldea M, Duruisseaux M, Perol M, Chouaid C, Bennouna J, Fallet V, Renault A, Guisier F, Giroux-Leprieur E, Wislez M, Toffart AC, Mazieres J, Basse C, Hegarat N, Carton M, Girard N. Lucibello F, et al. Among authors: wislez m. JTO Clin Res Rep. 2024 Oct 17;6(1):100743. doi: 10.1016/j.jtocrr.2024.100743. eCollection 2025 Jan. JTO Clin Res Rep. 2024. PMID: 39850629 Free PMC article.
COMPOSIT study: evaluating osimertinib combination with targeted therapies in EGFR-mutated non-small cell lung cancer.
Mehlman C, Swalduz A, Monnet I, Morin C, Wislez M, Guisier F, Curcio H, Du Rusquec P, Cortot AB, Gounant V, Abbar B, Duchemann B, Giroux-Leprieur E, Pierret T, Quilot FM, Cadranel J, Fallet V. Mehlman C, et al. Among authors: wislez m. Oncologist. 2024 Dec 26:oyae312. doi: 10.1093/oncolo/oyae312. Online ahead of print. Oncologist. 2024. PMID: 39724403 Free article.
[A 2024 inventory in oncology news].
Vignot S, Bellesoeur A, Bouleuc C, Cohen R, Courtier B, Crozier C, De Nonneville A, Delom F, Evrard S, Firmin N, Gandemer V, Khettab M, Magné N, Orbach D, Pellier I, Rodrigues M, Wislez M, Bay JO. Vignot S, et al. Among authors: wislez m. Bull Cancer. 2025 Jan;112(1):19-34. doi: 10.1016/j.bulcan.2024.12.001. Epub 2024 Dec 16. Bull Cancer. 2025. PMID: 39690092 Free article. Review. French.
Differential predictive value of resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy.
Paolini L, Tran T, Corgnac S, Villemin JP, Wislez M, Arrondeau J, Johannes L, Ulmer J, Vieillard LV, Pineau J, Gey A, Quiniou V, Barennes P, Pham HP, Gruel N, Hasan M, Libri V, Mella S, De Percin S, Boudou-Rouquette P, Caidi A, Cremer I, Blons H, Leroy K, Laurent-Puig P, De Saint Basile H, Gibault L, Ravel P, Mami-Chouaib F, Goldwasser F, Fabre E, Damotte D, Tartour E. Paolini L, et al. Among authors: wislez m. J Immunother Cancer. 2024 Dec 3;12(12):e009440. doi: 10.1136/jitc-2024-009440. J Immunother Cancer. 2024. PMID: 39631852 Free PMC article.
Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort.
Swalduz A, Beau-Faller M, Planchard D, Mazieres J, Bayle-Bleuez S, Debieuvre D, Fallet V, Geier M, Cortot A, Couraud S, Daniel C, Domblides C, Pichon E, Fabre E, Larivé S, Lerolle U, Tomasini P, Wislez M, Missy P, Morin F, Westeel V, Auliac JB. Swalduz A, et al. Among authors: wislez m. Lung Cancer. 2024 Nov 26;199:108038. doi: 10.1016/j.lungcan.2024.108038. Online ahead of print. Lung Cancer. 2024. PMID: 39616778
Biased cell adhesion organizes the Drosophila visual motion integration circuit.
Carrier Y, Quintana Rio L, Formicola N, de Sousa-Xavier V, Tabet M, Chen YD, Ali AH, Wislez M, Orts L, Borst A, Pinto-Teixeira F. Carrier Y, et al. Among authors: wislez m. Dev Cell. 2024 Nov 13:S1534-5807(24)00638-5. doi: 10.1016/j.devcel.2024.10.019. Online ahead of print. Dev Cell. 2024. PMID: 39549704
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08-2015 ENERGY): a randomised, open-label, phase 3 study.
Léna H, Greillier L, Cropet C, Bylicki O, Monnet I, Audigier-Valette C, Falchero L, Vergnenègre A, Demontrond P, Geier M, Guisier F, Hominal S, Locher C, Corre R, Chouaid C, Ricordel C; GFPC 08–2015 ENERGY investigators. Léna H, et al. Lancet Respir Med. 2024 Oct 29:S2213-2600(24)00264-9. doi: 10.1016/S2213-2600(24)00264-9. Online ahead of print. Lancet Respir Med. 2024. PMID: 39486424
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.
Birsen G, Gounant V, Girard N, Cadranel J, Monnet I, Raynaud-Donzel C, Fabre E, Giroux Leprieur E, Leroy K, Damotte D, Alifano M, Arrondeau J, Cremer I, Chapron J, Wislez M. Birsen G, et al. Among authors: wislez m. Transl Lung Cancer Res. 2024 Sep 30;13(9):2212-2221. doi: 10.21037/tlcr-24-263. Epub 2024 Sep 12. Transl Lung Cancer Res. 2024. PMID: 39430330 Free PMC article.
280 results